Invesaro

Stocks Health care PRCT

NASDAQ · Health care

PROCEPT BioRobotics Corp (PRCT)

PROCEPT BioRobotics Corp brought in $337.3M of revenue over the twelve months to June 30, 2026, up 22.7% from a year earlier. It posted a net loss of $109.8M. In fiscal 2025 capital spending exceeded operating cash flow by $58.3M. At June 30, 2026 it held $227.9M in cash against $51.7M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 5, 2026.

Revenue (last 12 months)
$337.3M
+22.7% year on year
Net margin
-32.5%

What PROCEPT BioRobotics Corp does

PROCEPT BioRobotics Corp is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker PRCT.

Revenue and profit by year

Revenue
FY21: $7.7M $7.7M FY21FY21: $34.5M $34.5M FY21FY22: $75M $75M FY22FY23: $136.2M $136.2M FY23FY24: $224.5M $224.5M FY24FY25: $308.1M $308.1M FY25
Net income
FY21: -$53M -$53M FY21FY21: -$59.9M -$59.9M FY21FY22: -$87.2M -$87.2M FY22FY23: -$105.9M -$105.9M FY23FY24: -$91.4M -$91.4M FY24FY25: -$95.6M -$95.6M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$308.1M-$103.9M-$95.6M-$1.72-$58.3M
2024$224.5M-$96.6M-$91.4M-$1.75-$103.6M
2023$136.2M-$109.2M-$105.9M-$2.24-$133.2M
2022$75M-$80.7M-$87.2M-$1.96-$83M
2021$34.5M-$54.2M-$59.9M-$3.63-$57.9M
2021$7.7M-$47.8M-$53M-$14.47-$48.6M

Latest SEC filings

What PROCEPT BioRobotics Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 24, 2026
  2. August 5, 2026
    Quarterly report 10-Q · period to June 30, 2026
  3. August 4, 2026
  4. July 29, 2026
  5. June 10, 2026
  6. June 1, 2026
  7. May 18, 2026
  8. April 30, 2026
    Quarterly report 10-Q · period to March 31, 2026
  9. April 30, 2026
  10. April 29, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 10, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about PRCT

What does PROCEPT BioRobotics Corp do?

PROCEPT BioRobotics Corp is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker PRCT.

Is PROCEPT BioRobotics Corp profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $109.8M on revenue of $337.3M.

How much revenue does PROCEPT BioRobotics Corp make?

Over the twelve months to June 30, 2026 PROCEPT BioRobotics Corp reported revenue of $337.3M. That is 22.7% more than a year earlier.

When did PROCEPT BioRobotics Corp last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 5, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the material agreement from September 24, 2026.

Similar companies

Follow PRCT

Get an email when PROCEPT BioRobotics Corp files with the SEC: results, executive changes, material agreements and annual reports.

Follow PRCT: get an email when it files

Where the numbers come from

Financial figures are the values PROCEPT BioRobotics Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.